{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T20:38:34Z","timestamp":1742935114819,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":13,"publisher":"Springer New York","isbn-type":[{"type":"print","value":"9781461471677"},{"type":"electronic","value":"9781461472094"}],"license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013]]},"DOI":"10.1007\/978-1-4614-7209-4_13","type":"book-chapter","created":{"date-parts":[[2013,6,13]],"date-time":"2013-06-13T21:09:37Z","timestamp":1371157777000},"page":"191-202","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Protein Expression Profiling of Brain Tumor Tissue Using SELDI-MS"],"prefix":"10.1007","author":[{"given":"Carl","family":"Wibom","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,5,16]]},"reference":[{"key":"13_CR00131","doi-asserted-by":"publisher","first-page":"148A","DOI":"10.1021\/ac031249c","volume":"75","author":"HJ Issaq","year":"2003","unstructured":"Issaq HJ, Conrads TP, Prieto DA, Tirumalai R, Veenstra TD (2003) SELDI-TOF MS for diagnostic proteomics. Anal Chem 75:148A\u2013155A","journal-title":"Anal Chem"},{"key":"13_CR00132","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1038\/sj.bjc.6603190","volume":"94","author":"C Wibom","year":"2006","unstructured":"Wibom C, Pettersson F, Sj\u00f6str\u00f6m M, Henriksson R, Johansson M, Bergenheim AT (2006) Protein expression in experimental malignant glioma varies over time and is altered by radiotherapy treatment. Br J Cancer 94:1853\u20131863","journal-title":"Br J Cancer"},{"key":"13_CR00133","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s11060-009-9865-9","volume":"94","author":"C Wibom","year":"2009","unstructured":"Wibom C, Moren L, Aarhus M, Knappskog PM, Lund-Johansen M, Antti H, Bergenheim AT (2009) Proteomic profiles differ between bone invasive and noninvasive benign meningiomas of fibrous and meningothelial subtype. J Neurooncol 94:321\u2013331","journal-title":"J Neurooncol"},{"key":"13_CR00134","unstructured":"CBTRUS (2009) CBTRUS 2009 Statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2004\u20132005, Central Brain Tumor Registry of the United States"},{"key":"13_CR00135","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S0360-3016(97)00317-9","volume":"39","author":"KS Condra","year":"1997","unstructured":"Condra KS, Buatti JM, Mendenhall WM, Friedman WA, Marcus RB Jr, Rhoton AL (1997) Benign meningiomas: primary treatment selection affects survival. Int J Radiat Oncol Biol Phys 39:427\u2013436","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"13_CR00136","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/jnen\/63.4.275","volume":"63","author":"K Lamszus","year":"2004","unstructured":"Lamszus K (2004) Meningioma pathology, genetics, and biology. J Neuropathol Exp Neurol 63:275\u2013286","journal-title":"J Neuropathol Exp Neurol"},{"key":"13_CR00137","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3171\/JNS-07\/11\/0905","volume":"107","author":"K Bikmaz","year":"2007","unstructured":"Bikmaz K, Mrak R, Al-Mefty O (2007) Management of bone-invasive, hyperostotic sphenoid wing meningiomas. J Neurosurg 107:905\u2013912","journal-title":"J Neurosurg"},{"key":"13_CR00138","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/COC.0b013e31816fc920","volume":"32","author":"BA Campbell","year":"2009","unstructured":"Campbell BA, Jhamb A, Maguire JA, Toyota B, Ma R (2009) Meningiomas in 2009: controversies and future challenges. Am J Clin Oncol 32:73\u201385","journal-title":"Am J Clin Oncol"},{"key":"13_CR00139","doi-asserted-by":"publisher","first-page":"E3","DOI":"10.3171\/FOC-07\/10\/E3","volume":"23","author":"DL Commins","year":"2007","unstructured":"Commins DL, Atkinson RD, Burnett ME (2007) Review of meningioma histopathology. Neurosurg Focus 23:E3","journal-title":"Neurosurg Focus"},{"key":"13_CR001310","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/prca.200600771","volume":"1","author":"H Mischak","year":"2007","unstructured":"Mischak H, Apweiler R, Banks RE, Conaway M, Coon J, Dominiczak A, Ehrich JHH, Fliser D, Girolami M, Hermjakob H, Hochstrasser D, Jankowski J, Julian BA, Kolch W, Massy ZA, Neusuess C, Novak J, Peter K, Rossing K, Schanstra J, Semmes OJ, Theodorescu D, Thongboonkerd V, Weissinger EM, Van Eyk JE, Yamamoto T (2007) Clinical proteomics: a need to define the field and to begin to set adequate standards. Proteomics Clin Appl 1:148\u2013156","journal-title":"Proteomics Clin Appl"},{"key":"13_CR001311","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/nrc1550","volume":"5","author":"DF Ransohoff","year":"2005","unstructured":"Ransohoff DF (2005) Bias as a threat to the validity of cancer molecular-marker research. Nat Rev Cancer 5:142\u2013149","journal-title":"Nat Rev Cancer"},{"key":"13_CR001312","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1021\/pr070482e","volume":"7","author":"J Forshed","year":"2008","unstructured":"Forshed J, Pernemalm M, Tan CS, Lindberg M, Kanter L, Pawitan Y, Lewensohn R, Stenke L, Lehtio J (2008) Proteomic data analysis workflow for discovery of candidate biomarker peaks predictive of clinical outcome for patients with acute myeloid leukemia. J Proteome Res 7:2332\u20132341","journal-title":"J Proteome Res"},{"key":"13_CR001313","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1515\/CCLM.2005.022","volume":"43","author":"M Aivado","year":"2005","unstructured":"Aivado M, Spentzos D, Alterovitz G, Otu HH, Grall F, Giagounidis AAN, Wells M, Cho JY, Germing U, Czibere A, Prall WC, Porter C, Ramoni MF, Libermann TA (2005) Optimization and evaluation of surface-enhanced laser desorption\/ionization time-of-flight mass spectrometry (SELDI-TOF MS) with reversed-phase protein arrays for protein profiling. Clin Chem Lab Med 43:133\u2013140","journal-title":"Clin Chem Lab Med"}],"container-title":["Methods in Molecular Biology","The Low Molecular Weight Proteome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4614-7209-4_13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T10:17:58Z","timestamp":1675333078000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-4614-7209-4_13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"ISBN":["9781461471677","9781461472094"],"references-count":13,"URL":"https:\/\/doi.org\/10.1007\/978-1-4614-7209-4_13","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2013]]},"assertion":[{"value":"16 May 2013","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}